Disclosures for "Efgartigimod is a Unique FcRn Blocker That Allows IgG Reduction Without Broad Inhibition of Immune Responses"
-
Sophie Steeland has received personal compensation for serving as an employee of argenx. Sophie Steeland has stock in argenx.
-
Ms. Heerlein has received personal compensation for serving as an employee of argenx. Ms. Heerlein has received personal compensation for serving as an employee of JNJ. Ms. Heerlein has or had stock in argenx.Ms. Heerlein has or had stock in JNJ.
-
Dr. Binazon has received personal compensation for serving as an employee of argenx. Dr. Binazon has stock in argenx.
-
Mr. Moshir has received personal compensation for serving as an employee of argenx BV.
-
Dr. Verhamme has received personal compensation for serving as an employee of argenx. Dr. Verhamme has stock in argenx.
-
Mrs. Gistelinck has nothing to disclose.
-
Dr. Podhorna has received personal compensation for serving as an employee of argenx. Dr. Podhorna has stock in argenx.